Discovery of novel orexin receptor antagonists using a 1,3,5-trioxazatriquinane bearing multiple effective residues (TriMER) library
Tsuyoshi Saitoh,Mao Amezawa,Jumpei Horiuchi,Yasuyuki Nagumo,Naoshi Yamamoto,Noriki Kutsumura,Ryuichiro Ohshita,Akihisa Tokuda,Yoko Irukayama-Tomobe,Yasuhiro Ogawa,Yukiko Ishikawa,Emi Hasegawa,Takeshi Sakurai,Yasuo Uchida,Tetsu Sato,Hiroaki Gouda,Ryuji Tanimura,Masashi Yanagisawa,Hiroshi Nagase
DOI: https://doi.org/10.1016/j.ejmech.2022.114505
2022-10-05
Abstract:Structurally diverse small compounds are utilized to obtain hit compounds that have suitable pharmacophores in appropriate three-dimensional conformations for the target drug receptors. We have focused on the 1,3,5-trioxazatriquinane skeleton, which has a rigid bowl-like structure enabling the diverse orientation of side chain units, leading to a novel small-scale focused library based on the skeleton. In the library screening for the orexin receptor, some of the compounds showed orexin receptor antagonistic activity with a high hit rate of 7%. By optimizing the hit compounds, we discovered a potent dual orexin receptor antagonist, 38b, and a selective orexin 1 receptor antagonist, 41b carrying the same plane structure. Both compounds showed reasonable brain permeability and beneficial effects when administered intraperitoneally to wild-type mice. Docking simulations of their eutomers, (-)-38b and (+)-41b, with orexin receptors suggested that the interaction between the 1,3,5-trioxazatriquinane core structure and the hydrophobic subpocket in orexin receptors enables a U-shape structure, which causes tight van der Waals interactions with the receptors similar to SB-334867, a selective orexin 1 receptor antagonist. These results indicate that the library approach utilizing the 1,3,5-trioxazatriquinanes bearing multiple effective residues (TriMERs) might be useful for the hit discovery process targeting not only opioid and orexin receptors but other G-protein coupled receptors.